A. Pertovaara and A. Koivisto, “TRPA1 Ion Channel in the Spinal Dorsal Horn as a Therapeutic Target in Central Pain Hypersensitivity and Cutaneous Neurogenic Inflammation,” European Journal of Pharmacology, Vol. 666, No. 1-3, 2011, pp. 1-4. doi:10.1016/j.ejphar.2011.05.027 [30] S. Türk and T. Kullisaar, “Are Prostatitis Symptoms Associated with an Isoprostane-Mediated Vicious Circle?” Medical Hypotheses, Vol. 77, No. 5, 2011, pp. 837-840. doi:10.1016/j.mehy.2011.07.050 [31] M. Pescuma, E. M. Hebert, F. Mozzi and G. F. de Valdes, “Functional Fermented Whey-Based Beverage Using Lactic Acid Bacteria,” International Journal of Food Microbiology, Vol. 141, No. 1-2, 2010, pp. 73-81. doi:10.1016/j.ijfoodmicro.2010.04.011 [32] O. W. Griffith, “Biologic and Pharmacologic Regulation of Mammalian Glutathione Synthesis,” Free Radical Biology and Medicine, Vol. 27, No. 9-10, 1999, pp. 922-935. doi:10.1016/S0891-5849(99)00176-8 [33] M. Zilmer, U. Soomets, A. Rehema and ü. Langel, “The Glutathione System as an Attractice Therapeutic Target,” Letters in Drug Design & Discovery, Vol. 2, 2005, pp. 121-127. [34] J. M. Hascoet, C. Hubert, F. Rochat, H. Legagneur, S. Gaga, S. Emady-Azar and P. G Steenhout, “Effect of Formula Composition on the Development of Infant Gut Microbiota,” Journal of Pediatric Gastroenterology and Nutrition, Vol. 52, No. 6, 2011, pp. 756-762. doi:10.1097/MPG.0 b013e3182105850 [35] G. Prioult and I. Fliss, “Effect of Probiotic Bacteria and Maintenance of Oral Tolerance to Beta-Lactoglobulin in Gnotobiotic Mice,” Clinical and Diagnostic Laboratory Immunology, Vol. 10, 2003, pp. 787-792. [36] J. M. Uronis, J. C. Arthur, T. Keku, A. Fodor, I. M. Carroll, M. L. Cruz, C. B. Appleyard and C. Jobin, “Gut Microbial Diversity Is Reduced by the Probiotic VSL#3 and Correlates with Decreased TNBS-Induced Colitis,” Inflammatory Bowel Diseases, Vol. 17, No. 1, 2011, pp. 289-297. doi:10.1002/ibd.21366 [37] N. Larsen, F. K. Vogensen, F. W. van den Berg, D. S. Nielsen, A. S. Andreasen, B. K. Pedersen, W. A. Al-Soud, S. J. Sorensen, L. H. Hansen and M. Jakobsen, “Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults,” PLoS One, Vol. 5, No. 2, 2010, Article ID: e9085. doi:10.1371/journal.pone.0009085 [38] L. Ramchandran and N. P. Shah, “Yogurt Can Beneficially Affect Blood Contributors of Cardiovascular Health Status in Hypertensive Rats,” Journal of Food Science, Vol. 76, No. 4, 2011, pp. 131-136. doi:10.1111/j.1750-3841.2011.02127.x [39] D. T. Dinh, A. G. Frauman, G. R. Somers, M. Ohishi, J. Zhou, D. J. Casley, C. I. Johnston and M. E. Fabiani, “Evidence for Activation of the Renin-Angiotensin System in the Human Prostate: Increased Angiotensin II and Reduced AT(1) Receptor Expression in Benign Prostatic Hyperplasia,” Journal of Pathology, Vol. 196, No. 2, 2002, pp. 213-219. doi:10.1002/path.1021 [40] A. von Ruesten, S. Feller, M. M. Bergmann and H. Boeing, “Diet and Risk of Chronic Diseases: Results from the First 8 Years of Follow-Up in the EPIC-Potsdam Study,” European Journal of Clinical Nutrition, Vol. 67, No. 4, 2013, pp. 412-419. doi:10.1038/ejcn.2013.7

comments powered by Disqus
OJU Subscription
E-Mail Alert
OJU Most popular papers
Publication Ethics & OA Statement
OJU News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.